Type 1 Diabetes in 2017 - Global Estimates of Incident and Prevalent Cases in Children and Adults

Green, Anders; Hede, Simone Møller; Patterson, Christopher; Imperatore, Giuseppina; Roglić, Gojka; Beran, David

doi:10.2139/ssrn.3751311

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent global estimates of type 1 diabetes (T1D) indicate that 40% of the 9 million cases are below age 40 years. The prevalence is about 10 times higher in high-income versus low-income countries (1). The COVID-19 crisis has led to global disruptions in routine models of outpatient and inpatient clinical care.…”

Section: Introductionmentioning

confidence: 99%

A Worldwide Perspective on COVID-19 and Diabetes Management in 22,820 Children from the SWEET Project: Diabetic Ketoacidosis Rates Increase and Glycemic Control Is Maintained

Danne

Lanzinger

Bock

et al. 2021

Diabetes Technology & Therapeutics

View full text Add to dashboard Cite

To investigate the short-term effects of the first wave of COVID-19 on clinical parameters in children with type 1 diabetes (T1D) from 82 worldwide centres participating in the SWEET registry.Methods: Aggregated data per person with T1D ≤ 21 years of age were compared between May/June 2020 (first wave), August/September 2020 (after wave) and the same periods in 2019. Hierarchic linear and logistic regression models were applied. Models were adjusted for gender, age-and diabetes duration-groups. To distinguish the added burden of the COVID-19 pandemic, the centres were divided into quartiles of first wave COVID-19 associated mortality in their country.

show abstract

Section: Introductionmentioning

confidence: 99%